Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Share-based Compensation: 2012-2024

Historic Share-based Compensation for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $24.4 million.

  • Amphastar Pharmaceuticals' Share-based Compensation rose 12.53% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.7 million, marking a year-over-year increase of 14.32%. This contributed to the annual value of $24.4 million for FY2024, which is 20.38% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Share-based Compensation stood at $24.4 million for FY2024, which was up 20.38% from $20.2 million recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Share-based Compensation peaked at $24.4 million during FY2024, and registered a low of $17.9 million during FY2022.
  • In the last 3 years, Amphastar Pharmaceuticals' Share-based Compensation had a median value of $20.2 million in 2023 and averaged $20.8 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first declined by 8.84% in 2021, then rose by 20.38% in 2024.
  • Amphastar Pharmaceuticals' Share-based Compensation (Yearly) stood at $20.5 million in 2020, then fell by 8.84% to $18.7 million in 2021, then declined by 4.43% to $17.9 million in 2022, then climbed by 13.34% to $20.2 million in 2023, then increased by 20.38% to $24.4 million in 2024.